Dr. Lihua Elizabeth Budde, MD, PhD
- Medicare services, 2024
- 381
- Medicare patients, 2024
- 112
- Part D claims, 2024
- 191
- Publications
- 59
- Clinical trials
- 6
- Practice address
- 1500 Duarte Rd, Duarte, CA 91010
- Practice phone
- Call (800) 826-4673
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
City of Hope Comprehensive Cancer Center - Duarte
Duarte, California
Find Dr. Budde's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Lihua Elizabeth Budde is a hematology (internal medicine) physician in Duarte, California
Dr. Budde practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.
Dr. Budde's NPI, 1124030028, was assigned on August 12, 2006. Dr. Budde graduated from Tongji Medical University in 1995. Dr. Budde holds California license A122611.
- NPI
- 1124030028NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4789735721
- NPI enumeration date
- August 12, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (800) 826-4673
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Lihua Elizabeth Budde practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California
Dr. Budde's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.
- City of Hope Comprehensive Cancer Center - Duarte1500 Duarte Rd, Duarte, CA 91010 · Los Angeles CountyPhone(800) 826-4673
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Lihua Elizabeth Budde is affiliated with 2 sites of care and 1 medical group
Dr. Budde's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Budde to 1 more other site, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Lihua Elizabeth Budde's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Budde practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| City of Hope Comprehensive Cancer Center - Duarte | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Lihua Elizabeth Budde is one of 153 hematology (internal medicine) physicians in California
Internal medicine is Dr. Budde's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Budde's licenses on file in 2 states: California and Washington.
Specialties and state licenses
- Hematology (internal medicine), CaliforniaPrimary
- Hematology and oncology, Washington
Clinical focus
Dmand AI lists chronic leukemia, immune deficiency disease, lymphoma and multiple myeloma among the conditions Dr. Budde treats.
Hematology (internal medicine) physicians near Dr. Budde
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Lihua Elizabeth Budde billed Medicare for 381 services in 2024
CMS data shows 381 Medicare services from Dr. Budde across 5 procedure codes in 2024, for 112 Medicare patients. Medicare paid $33,804 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Budde's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4132024: 35714%
- Other services
- 2023: 02024: 24
Dr. Budde compared with the California median for hematology (internal medicine) physicians, 2024
- Dr. Budde
- California median
- Medicare services
- 381vs 373Close to median
- Medicare patients
- 112vs 109Close to median
- Part D claims
- 111vs 9912% above
Medians across 139 hematology (internal medicine) physicians in California with Dmand AI profiles that report each measure.
Dr. Budde's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Budde?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Budde and other hematology (internal medicine) physicians in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Lihua Elizabeth Budde treated 112 Medicare patients in 2024, average age 71
CMS counts 112 Medicare patients who saw Dr. Budde in 2024. The largest group is 65 to 74, with 63 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Budde's median patient age at 69, with 50% women.
Dr. Budde's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Budde's Medicare patients by sex, 2024
- Women5751%
- Men5549%
Chronic conditions among Dr. Budde's Medicare patients, 2024
- High blood pressure69%
- High cholesterol68%
- Arthritis38%
- Diabetes33%
- Ischemic heart disease31%
- Anxiety28%
- Chronic kidney disease24%
- Mood disorders24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Budde's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women50%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Lihua Elizabeth Budde wrote 191 Medicare Part D claims in 2024
In 2024, Dr. Budde wrote 191 Medicare Part D claims for 36 patients. 76% of them were for generic drugs. CMS names the drug for 111 of them, across 4 drugs with 11 or more claims each, at $215,502 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.
Dr. Budde's Part D claims by kind of drug, 2024
- Generic145 claims76%
- Brand-name46 claims24%
Dr. Budde's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Budde's Part D claims, 2024
- Antibiotics15%28 of 191 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 242024: 111363%
Drugs named by CMS: 4 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Lihua Elizabeth Budde scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Budde for performance year 2024, reported as part of a group. Dr. Budde accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Budde as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Budde's MIPS scores, performance year 2024
- 93of 100Final score
- 78.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 70of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Lihua Elizabeth Budde has 59 publications on record
Dmand AI links 59 papers to Dr. Budde, published from 2010 to 2024. 2023 was the busiest year, with 8. The most frequent topics are Immunotherapy, Adoptive, Receptors, Chimeric Antigen and Antigens, CD19. Dr. Budde has published most often in Blood. Dr. Budde's most frequent co-authors are Stephen J. Forman, MD, Matthew Genyeh Mei, MD and Alex F. Herrera, MD.
Dr. Budde's papers by year, 2013 to 2024
Topics Dr. Budde writes about most
- Immunotherapy, Adoptive
- Receptors, Chimeric Antigen
- Antigens, CD19
- Lymphoma, Large B-Cell, Diffuse
- T-Lymphocytes
- Antibodies, Bispecific
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
Dr. Budde's most frequent co-authors
- Stephen J. Forman, MD20 shared papers
- Matthew Genyeh Mei, MD13 shared papers
- Alex F. Herrera, MD11 shared papers
Recent publications by Dr. Budde
Transplant Cell Ther
See who Dr. Budde researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Budde works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Lihua Elizabeth Budde has worked on 6 clinical trials
Dmand AI links Dr. Budde to 6 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Blastic Plasmacytoid Dendritic Cell Neoplasm and Lymphoma, Extranodal NK-T-Cell. City of Hope Medical Center sponsors the most, 3.
Clinical trials with Dr. Budde by phase
- 2Phase 1: 2 trials
- 2Phase 1/2: 2 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Budde's trials
- Lymphoma, Large B-Cell, Diffuse
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
Investigators on the most trials with Dr. Budde
- Ahmad Sami Halwani, MD2 shared trials
- Ranjana Advani, MD1 shared trial
- Stephen M. Ansell, MD1 shared trial
Recent clinical trials with Dr. Budde
Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (opens in a new tab)
Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia (opens in a new tab)
A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma (opens in a new tab)
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Lihua Elizabeth Budde received $208,433 in industry payments from 2016 to 2025
CMS Open Payments shows 281 general payments to Dr. Budde from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $87,934. It also lists 50 research payments totaling $34,375 from 2020 to 2025.
General payments to Dr. Budde by program year, 2016 to 2025
General payments to Dr. Budde by kind, 2016 to 2025
- Consulting fees$98,38447%
- Travel and lodging$52,54025%
- Speaker and faculty fees$45,46022%
- Food and beverage$8,7574%
- Other$3,1832%
Companies that paid Dr. Budde the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Lihua Elizabeth Budde has 1 award and honors on record
Dmand AI lists 1 award for Dr. Budde.
Awards and honors for Dr. Budde
- Undated
- Clinical investigator
Source: Dmand AI Professional Profile Data
Dr. Lihua Elizabeth Budde graduated from Tongji Medical University
Dr. Budde graduated from Tongji Medical University in 1995.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Lihua Elizabeth Budde accepts plans from 14 insurance carriers
Dr. Budde is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Elevance
- HCSC
- Blue Cross Blue Shield of Massachusetts
- AK State Medicaid
- Alliant Health Plans
- +6 more carriersWith a free account
Plan types Dr. Budde accepts, by number of carriers
- PPO8
- HMO6
- Medicare6
- EPO4
- POS3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Lihua Elizabeth Budde's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Lihua Elizabeth Budde
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Lihua Elizabeth Budde's NPI number?
Dr. Lihua Elizabeth Budde's NPI number is 1124030028. It was assigned on August 12, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Lihua Elizabeth Budde?
Dr. Lihua Elizabeth Budde is a hematology (internal medicine) physician in Duarte, California. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. Lihua Elizabeth Budde practice?
Dr. Budde practices at 1500 Duarte Rd, Duarte, CA 91010. Dr. Budde's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dmand AI also links Dr. Budde to 1 other site.
What is Dr. Lihua Elizabeth Budde's office phone number?
The practice phone on file for Dr. Budde is (800) 826-4673.
What is Dr. Lihua Elizabeth Budde's medical license number?
Dr. Budde holds California license A122611, one of the licenses on file in 2 states.
Which states has Dr. Lihua Elizabeth Budde been licensed in?
Dmand AI has state licenses on file for Dr. Budde in California (2012 to 2026) and Washington (2006 to 2013).
What medical group is Dr. Lihua Elizabeth Budde part of?
Dr. Budde is linked to City of Hope.
Does Dr. Lihua Elizabeth Budde accept Medicare?
Yes. CMS data shows Dr. Budde billed Medicare for 381 services in 2024, and Dr. Budde accepts Medicare assignment.
Does Dr. Lihua Elizabeth Budde offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Budde as offering telehealth services.
What is Dr. Lihua Elizabeth Budde's MIPS score?
Dr. Budde's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.
Show 9 more questionsShow fewer questions
How many Medicare patients does Dr. Lihua Elizabeth Budde see?
CMS counts 112 Medicare patients who saw Dr. Budde in 2024, with an average age of 71.
What services does Dr. Lihua Elizabeth Budde bill to Medicare?
In 2024, Dr. Budde's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99232).
Where did Dr. Lihua Elizabeth Budde go to medical school?
Dr. Budde graduated from Tongji Medical University in 1995.
What drugs does Dr. Lihua Elizabeth Budde prescribe most?
In 2024 Medicare Part D data, Dr. Budde's most prescribed drugs by claims were Acyclovir, Sulfamethoxazole-Trimethoprim and Allopurinol.
Has Dr. Lihua Elizabeth Budde received payments from drug or device companies?
CMS Open Payments shows $208,433 in general payments to Dr. Budde from 23 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Lihua Elizabeth Budde been practicing?
Dr. Budde graduated from medical school in 1995, 31 years ago.
Does Dr. Lihua Elizabeth Budde do research?
Dmand AI links 59 publications to Dr. Budde, published from 2010 to 2024. Dr. Budde has worked on 6 clinical trials.
Who does Dr. Lihua Elizabeth Budde publish with?
Dr. Budde's most frequent co-authors are Stephen J. Forman, MD (20 shared papers), Matthew Genyeh Mei, MD (13 shared papers) and Alex F. Herrera, MD (11 shared papers).
What insurance does Dr. Lihua Elizabeth Budde accept?
Dr. Budde is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See hematology (internal medicine) physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card